Endo International plc (NASDAQ:ENDP) Expected to Announce Earnings of $0.46 Per Share

Share on StockTwits

Wall Street analysts forecast that Endo International plc (NASDAQ:ENDP) (TSE:ENL) will announce $0.46 earnings per share for the current quarter, Zacks reports. Six analysts have issued estimates for Endo International’s earnings. The highest EPS estimate is $0.72 and the lowest is $0.41. Endo International reported earnings of $0.74 per share during the same quarter last year, which would suggest a negative year-over-year growth rate of 37.8%. The firm is expected to announce its next quarterly earnings report on Wednesday, February 24th.

On average, analysts expect that Endo International will report full year earnings of $2.55 per share for the current fiscal year, with EPS estimates ranging from $2.53 to $2.60. For the next fiscal year, analysts anticipate that the company will report earnings of $2.34 per share, with EPS estimates ranging from $2.11 to $2.63. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that follow Endo International.

Endo International (NASDAQ:ENDP) (TSE:ENL) last posted its quarterly earnings data on Thursday, November 5th. The company reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.38. Endo International had a negative net margin of 5.25% and a negative return on equity of 91.41%. The firm had revenue of $634.86 million for the quarter, compared to analyst estimates of $550.63 million. During the same period last year, the firm posted $0.66 EPS. Endo International’s quarterly revenue was down 13.0% on a year-over-year basis.

A number of equities analysts recently weighed in on ENDP shares. Piper Sandler lifted their price objective on shares of Endo International from $5.00 to $6.00 and gave the company an “overweight” rating in a research report on Friday, October 9th. BidaskClub lowered shares of Endo International from a “buy” rating to a “hold” rating in a research report on Wednesday, November 4th. Morgan Stanley lifted their price objective on shares of Endo International from $3.00 to $4.00 and gave the company an “underweight” rating in a research report on Thursday, November 12th. ValuEngine lowered shares of Endo International from a “sell” rating to a “strong sell” rating in a research report on Wednesday, November 11th. Finally, The Goldman Sachs Group started coverage on shares of Endo International in a research report on Monday, July 27th. They set a “sell” rating and a $3.00 target price on the stock. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $5.50.

NASDAQ:ENDP opened at $5.04 on Tuesday. The firm’s fifty day moving average price is $4.66 and its 200 day moving average price is $3.79. Endo International has a 1-year low of $2.08 and a 1-year high of $7.10. The firm has a market cap of $1.16 billion, a price-to-earnings ratio of -7.41 and a beta of 1.30.

Several hedge funds and other institutional investors have recently modified their holdings of the business. Arizona State Retirement System increased its holdings in shares of Endo International by 6.9% during the second quarter. Arizona State Retirement System now owns 51,198 shares of the company’s stock valued at $176,000 after purchasing an additional 3,283 shares during the period. Cim Investment Mangement Inc. increased its holdings in shares of Endo International by 20.4% during the second quarter. Cim Investment Mangement Inc. now owns 20,558 shares of the company’s stock valued at $71,000 after purchasing an additional 3,490 shares during the period. State of Tennessee Treasury Department increased its holdings in shares of Endo International by 3.3% during the third quarter. State of Tennessee Treasury Department now owns 134,401 shares of the company’s stock valued at $444,000 after purchasing an additional 4,296 shares during the period. California State Teachers Retirement System increased its holdings in shares of Endo International by 1.4% during the second quarter. California State Teachers Retirement System now owns 344,348 shares of the company’s stock valued at $1,181,000 after purchasing an additional 4,773 shares during the period. Finally, UBS Asset Management Americas Inc. increased its holdings in shares of Endo International by 3.5% during the third quarter. UBS Asset Management Americas Inc. now owns 166,331 shares of the company’s stock valued at $549,000 after purchasing an additional 5,556 shares during the period. Institutional investors own 80.21% of the company’s stock.

Endo International Company Profile

Endo International plc manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; TESTOPEL for TRT in conditions associated with a deficiency or absence of endogenous testosterone; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; VOLTAREN gel for the relief of joint pain of osteoarthritis; LIDODERM for the relief of pain; TESTOPEL, an implantable pellet indicated for TRT in conditions; EDEX to treat erectile dysfunction; and LIDODERM a topical patch product containing lidocaine.

Featured Article: What is required to own or exchange cryptocurrency?

Get a free copy of the Zacks research report on Endo International (ENDP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Endo International (NASDAQ:ENDP)

Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply